Skip to main content

Advertisement

Log in

Granulocyte Stimulating Factor in Patients on Peritoneal Dialysis and LPS Stimulated Peripheral Blood Mononuclear Cells

  • Published:
Inflammation Aims and scope Submit manuscript

Abstract

Dialysate and serum levels of granulocyte-colony stimulating factor (G-CSF), granulocyte macrophage colony stimulating factor (GM-CSF) and leukemia inhibitory factor (LIF) were analyzed in patients with continuous ambulatory peritoneal dialysis (CAPD). Samples from the peritoneal effluent and from serum were obtained during the first months of dialysis and during peritonitis from the first three dialysate bags drained on the day of admittance and from nightbags on days three and ten. Serum samples were drawn on days one and ten. On the first day of infection G-CSF was detected in twelve out of fifteen samples in the dialysate and reached its peak median level, 443 pg/ml, in the first drained bag and thereafter decreased significantly. Also in serum a peak, 190 pg/ml, was observed on the first day. LIF was found in six of ten analyzed dialysate samples, with a peak median level of 77 pg/ml on day one, while only four of ten patients had detectable GM-CSF. Peripheral blood mononuclear cells from non-infected CAPD patients were stimulated with lipopolysacharide and G-CSF levels in the supernatants increased significantly (P < 0.05) after 6 h stimulation. We conclude that G-CSF is produced locally in the dialysate during the acute stage of peritonitis and to a lesser extent also systemically. These findings are in line with G-CSF production after LPS stimulation of peripheral blood mononuclear cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. Weisbart, R. H., J. C. Gasson, and D. W. Golde. 1989. Colony-stimulating factors and host defense. Ann. Intern. Med. 110:297–303.

    PubMed  Google Scholar 

  2. Souoza, L. M., T. C. Boone, J. Bagrilove, P. H. Lai, K. Zsebo, D. C. Murdock, V. R. Chazin, J. Bruszewski, H. Lu, K. K. Chen, J. Barendt, E. Platzer, M. A. S. Moore, R. Mertelsmann, and K. Welte. 1986. Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells. Science 232:61–65.

    PubMed  Google Scholar 

  3. Freedman, M. H. 1997. Safety of long-term administration of granulocyte colony-stimulating factor for severe chronic neutropenia. Curr. Opinion Hematol. 4:217–224.

    Google Scholar 

  4. Nelson, S. 1994. Role of granulocyte colony-stimulating factor in the immune response to acute bacterial infection in the non-neutropenic host: an overview. Clin. Infect. Dis. 18(Suppl 2):S197–204.

    PubMed  Google Scholar 

  5. Roilides, E. and P.A. Pizzo. 1992. Modulation of host defenses by cytokines: evolving adjuncts in prevention and treatment of serious infections in immunocompromised hosts. Clin. Infect. Dis. 15:508–524.

    PubMed  Google Scholar 

  6. Selgas, R., M. Fernadez de Castro, C. Jimenez, C. Carcamo, T. Contreras, M. A. Bajo, F. Vara, and A. Corbi. 1996. Immunomodulation of peritoneal macrophages by granulocyte-macrophage colony stimulating factor in humans. Kidn. Int. 50:2070–2078.

    Google Scholar 

  7. Mayer, P., K. Geissler, M. Ward, and D. Metcalf. 1993. Recombinant human leukemia inhibitory factor induces acute phase proteins and raises the blood platelet counts in nonhuman primates. Blood 81:3226–3333.

    PubMed  Google Scholar 

  8. Block, M. I., M. Berg, M. J. McNamara, J. A. Norton, D. L. Fraker, and H. R. Alexander. 1993. Passive immunization of mice against D factor blocks lethality and cytokine release during endotoxemia. J. Exp. Med. 178:1085–1090.

    Article  PubMed  Google Scholar 

  9. Cebon, J., J. E. Laytonn, D. Maher, and G. Morstyn. 1994. Endogenous haemopoietic growth factors in neutropenia and infection. Br. J. Haematol. 86:265–274.

    PubMed  Google Scholar 

  10. Kawakami, M., H. Tsutsumi, T. Kumakawa, H. Abe, M. Hirai, S. Kurosawa, M. Mori, and M. Fukushima. 1990. Levels of serum granulocyte colony-stimulating factor in patients with infections. Blood 76:1962–1964.

    PubMed  Google Scholar 

  11. Price, T. H., G. S. Chatta, and D. C. Dale. 1996. Effect of recombinat granulocyte colony-stimulating factor on neutrophil kinetics in normal young and elderly humans. Blood 88:335–340.

    PubMed  Google Scholar 

  12. De Vecci, A., P. Zanon, A. Scalamogna, and C. Ponticelli. 1994. Granulocyte-colonystimulating factor in patients treated by continuous ambulatory peritoneal dialysis. Nephrol. Dial. Transpl. 9:1843–1844.

    Google Scholar 

  13. Dale, D. C., W. C. Liles, W. R. Summer, and S. Nelson. 1995. Granulocyte colony-stimulating factor-role and relationships in infectious diseases. J. Infect. Dis. 172:1061–1075.

    PubMed  Google Scholar 

  14. Krause, S. W., M. Kreutz, and R. Andreesen. 1997. Differential effects of cell adherence on LPS-stimulated cytokine production by human monocytes and macrophages. Immunobiol. 196:522–534.

    Google Scholar 

  15. Rennick, D., G. Yang, L. Gemmel, and F. Lee. 1987. Control of hemopoiesis by bone marrow stromal cell clone: lipopolysaccharide-and interleukin-1 inducible production of colony-stimulating factors. Blood 69:682–691.

    PubMed  Google Scholar 

  16. Fernandez de Castro, M., R. Selgas, C. Jimenez, M. A. Bajo, V. Martinez, J. Romero, F. De Alvaro, and F. Vara. 1994. Cell populations present in the noctural peritoneal effluent of patients on CAPD and their relationship with peritoneal function and incidence of peritonitis. Perit. Dial. Int. 14:265–270.

    PubMed  Google Scholar 

  17. Lopez, A. F., D. J. Williamson, J. R. Gamble, C. G. Beoley, J. M. Harlan, S. J. Klebanoff, A. Waltersdorph, G. Wong, S. C. Clark, and M. A. Vadas. 1986. Recombinant human granulocyte-macrophage colony stimulating factor stimulates in vitro mature human neutrophil and eosinophil function, surface receptor expression and survival. J. Clin. Invest. 78:1220–1228.

    PubMed  Google Scholar 

  18. Waring, P. M., L. J. Waring, and D. Metcalf. 1994. Circulating leukemia inhibitory factor levels correlate with disease severity in meningococcema. J. Infect. Dis. 170:1224–1228.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Brauner, A., Hylander, B. & Lu, Y. Granulocyte Stimulating Factor in Patients on Peritoneal Dialysis and LPS Stimulated Peripheral Blood Mononuclear Cells. Inflammation 22, 393–401 (1998). https://doi.org/10.1023/A:1022320916105

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1022320916105

Keywords

Navigation